Sale of 25,000 shares at $23.9838 per share.
Reporting Person Evans John M. · Officer Title CEO · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001193125-26-424421 · filed 2026-10-16 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Beam Therapeutics Inc. (BEAM)." Disclosed 2026-10-16. https://desqlong.com/cards/0001193125-26-424421-4 (retrieved 2026-10-17).